FI963638A - Procedures for the diagnosis and treatment of HIV-1 infection - Google Patents

Procedures for the diagnosis and treatment of HIV-1 infection Download PDF

Info

Publication number
FI963638A
FI963638A FI963638A FI963638A FI963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A
Authority
FI
Finland
Prior art keywords
hiv
infection
diagnosis
procedures
treatment
Prior art date
Application number
FI963638A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI963638A0 (en
Inventor
Angeline Douvas
Glenn Ehresmann
Yoshi Takehana
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of FI963638A0 publication Critical patent/FI963638A0/en
Publication of FI963638A publication Critical patent/FI963638A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16111Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI963638A 1994-03-14 1996-09-13 Procedures for the diagnosis and treatment of HIV-1 infection FI963638A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21374394A 1994-03-14 1994-03-14
PCT/US1995/003236 WO1995025124A1 (en) 1994-03-14 1995-03-13 Methods to diagnose and treat hiv-1 infection

Publications (2)

Publication Number Publication Date
FI963638A0 FI963638A0 (en) 1996-09-13
FI963638A true FI963638A (en) 1996-11-13

Family

ID=22796323

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963638A FI963638A (en) 1994-03-14 1996-09-13 Procedures for the diagnosis and treatment of HIV-1 infection

Country Status (6)

Country Link
EP (1) EP0750636A1 (en)
JP (1) JPH10504798A (en)
CA (1) CA2185129A1 (en)
FI (1) FI963638A (en)
NO (1) NO963848L (en)
WO (1) WO1995025124A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2358385C (en) 1998-12-31 2013-08-06 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
EP1411770A4 (en) 2001-07-05 2006-05-10 Chiron Corp Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
DE60234843D1 (en) * 2001-09-06 2010-02-04 Centre Nat Rech Scient MODIFIED PEPTIDES AND THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISEASES
CN101588813A (en) * 2005-04-12 2009-11-25 杜克大学 Method of inducing neutralizing antibodies to human immunodeficiency virus
TW200726479A (en) 2005-04-12 2007-07-16 Univ Duke Method of inducing neutralizing antibodies to human immunodeficiency virus
EP2139516A4 (en) 2007-04-13 2011-06-29 Univ Duke Method of inducing neutralizing antibodies to human immunodeficiency virus
AU2010232915A1 (en) 2009-04-03 2011-10-20 Duke University Formulation for inducing broadly reactive neutralizing anti-HIV antibodies
US10076567B2 (en) 2013-09-27 2018-09-18 Duke University MPER-liposome conjugates and uses thereof
US10213482B2 (en) 2014-12-12 2019-02-26 Immupharma France Sa Methods of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
FI963638A0 (en) 1996-09-13
WO1995025124A1 (en) 1995-09-21
CA2185129A1 (en) 1995-09-21
AU2120595A (en) 1995-10-03
EP0750636A1 (en) 1997-01-02
JPH10504798A (en) 1998-05-12
NO963848D0 (en) 1996-09-13
AU694204B2 (en) 1998-07-16
NO963848L (en) 1996-11-14

Similar Documents

Publication Publication Date Title
FI952926A0 (en) Procedures for the treatment and prevention of all Procedures for the treatment and prevention of allergies ergies
FI971969A (en) Compositions for the treatment of hemorrhoids and method of use
NO952573D0 (en) Preparations for the treatment of diabetic complications
FI963281A (en) Urea-based vaccine and treatment of helicobacterial infection
DE69822410D1 (en) Modular catheter for imaging and treatment and assembly procedures
FI970918A0 (en) Compounds and methods for the treatment of cancer
FI94028B (en) Device for the diagnosis and treatment of nasal diseases
FI19992398A (en) Procedures and arrangements for the identification of heartbeats
DE69115626D1 (en) Medical device for endoscopic surgery
FI951370A (en) Thiazolidine and oxazolidine derivatives, their preparation and their medical use
DE69635364D1 (en) Blood filter and extracorporeal circulation
FI971568A (en) Procedure for the treatment of resistant tumors
FI965204A (en) Medical use of bromelain
DE69603635D1 (en) Catheter structure for medical treatment
DE69620691D1 (en) Therapeutic agent for the treatment of hypercholesterolemia
BR9101494A (en) TISSUE TREATMENT
FI963638A (en) Procedures for the diagnosis and treatment of HIV-1 infection
ATA113492A (en) MULTIPLE POUCH SYSTEM FOR THE STERILE TREATMENT OF HUMAN BLOOD PRESERVES
FI971897A (en) Detection of human retroviral infection
NO913117D0 (en) PROCEDURE FOR THE TREATMENT OF NECESSARY DISEASES.
FI964113A0 (en) Medical composition for the treatment of tardive dyskinesia and its use
NO965591D0 (en) Combination treatment of HIV infection
FI963947A (en) Completely dissolved bone tissue and procedure for making the same
FI963263A0 (en) Medical use of bromelain
DE69522685D1 (en) TREATMENT OF BLOOD PLASMA

Legal Events

Date Code Title Description
MA Patent expired